Wikidata

(Q61965754)

English

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

clinical trial

In more languages

Statements

short name
RECOMMEND (English)
0 references
title
A Multinational, Open Label, Randomized, Active-controlled, 3-arm Parallel Group, 24-week Study Comparing the Combination of Glimepiride and Metformin Versus Glimepiride and Metformin Alone in Patients With Type 2 Diabetes (English)
0 references
sponsor
Sanofi
0 references
country
Algeria
0 references
Colombia
0 references
Egypt
0 references
Guatemala
0 references
India
0 references
Lebanon
0 references
Mexico
0 references
South Africa
0 references
Tunisia
0 references
Turkey
0 references
Ukraine
0 references
United Arab Emirates
0 references
start time
February 2012
0 references
end time
January 2014
0 references
number of participants
538
0 references
research intervention
glimepiride
0 references
metformin
0 references
minimum age
18 year
0 references
maximum age
78 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61965754&oldid=2098425026"